A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

Treatment of human epidermal growth factor receptor-2 (HER2)-positive breast cancer with dual anti-HER2 therapy has been shown to improve outcomes. In the present pilot phase II study, patients with early-stage HER2-positive breast cancer received adjuvant treatment with dose-dense paclitaxel, trast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Breast Cancer
Main Authors: Iyengar, Neil M., Fornier, Monica N., Sugarman, Steven M., Theodoulou, Maria, Troso-Sandoval, Tiffany A., D’Andrea, Gabriella M., Drullinsky, Pamela R., Gajria, Devika, Goldfarb, Shari B., Comen, Elizabeth A., Lake, Diana E., Modi, Shanu, Traina, Tiffany A., Lacouture, Mario E., Chen, Melanie F., Patil, Sujata, Baselga, José, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968930/
https://ncbi.nlm.nih.gov/pubmed/26454612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.09.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados